Terkko Navigator / Yki-Järvinen, H(annele)*

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515)

Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity

Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease

The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults

MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans

The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue

Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort^☆

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease

Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions

Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling

Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans

Reply to Krahn and Sebastiani

Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids

Effects of Weighted Hula-Hooping Compared to Walking on Abdominal Fat, Trunk Muscularity, and Metabolic Parameters in Overweight Subjects: A Randomized Controlled Study

Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers

Diabetes, Liver Cancer, and Cirrhosis: What Next?

Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars

Diagnosis of nonalcoholic fatty liver disease (NAFLD)

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study

Fat accumulates preferentially in the right rather than the left liver lobe in non-diabetic subjects

Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 Diabetes

Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study

Gene expression profile of subcutaneous adipose tissue in BMI-discordant monozygotic twin pairs unravels molecular and clinical changes associated with sub-types of obesity

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD

Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease

Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans

Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease

The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans

Non-alcoholic fatty liver disease and risk of type 2 diabetes

Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites

Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review

Diagnosis of non-alcoholic fatty liver disease (NAFLD)

Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

MicroRNA-192* impairs adipocyte triglyceride storage